Distinct roles of general anesthesia activated CeA neurons in acute versus late phase of neuropathic pain

Junli Zhao,Kenta Furutani,Aidan McGinnis,Joseph P Mathew,Fan Wang,Ru-Rong Ji
DOI: https://doi.org/10.1101/2024.09.11.612553
2024-09-14
Abstract:A previous study discovered a distinct population of GABAergic neurons in the ntral mygdala (CeA) that can be activated by eneral nesthesia (CeA ) and exert analgesic functions (Hua et al., 2020). To independently reproduce these prior findings and to investigate the electrophysiological properties of CeA neurons, we first used 1.2% isoflurane to induce c-Fos activation in the mouse brain and validated the expression by RNAscope hybridization. Indeed, isoflurane induced robust Fos expression in CeA and these Fos CeA neurons are GABAergic neurons (Vgat ). We next used Fos-TRAP2 method (different from the CANE method used in the prior study) to label CeA neurons (tdTomato ). Our electrophysiological recordings in brain slices revealed that compared to Fos-negative CeA neurons, CeA neurons had significantly higher excitability and exhibited distinct patterns of action potentials. Chemogenetic activation of Fos-TRAPed CeA neurons was effective at increasing pain thresholds in naïve mice and mice with early-phase neuropathic pain 2 weeks after spared nerve injury (SNI). However, the same chemogenetic activation of CeA neurons only had modest analgesia in the late phase of SNI at 8 weeks, although it was highly effective in reducing chronic pain-associated anxiety behaviors at this stage. We found that Fos-negative CeA neurons, but not CeA neurons, exhibited increased excitability in the late-phase of SNI, suggesting that chronic pain causes a shift in the relative activity of the CeA microcircuit. Interestingly, Fos-negative neurons exhibited much higher expression of K -Cl cotransporter-2 (KCC2), and KCC2 expression was downregulated in the CeA in the late-phase of neuropathic pain. These results support the idea that targeting CeA neurons may provide therapeutic benefits for pain relief and chronic pain-associated anxiety. Our findings also suggest distinct roles of CeA neurons in regulating physiological pain, acute pain, and chronic pain with a possible involvement of KCC2.
Neuroscience
What problem does this paper attempt to address?